Thoughts on Traditional Chinese Medicine Treatment of Novel Coronavirus Pneumonia Based on Two Cases.
作者信息
Ma Jie, Wu Hua-Yang, Chen Yu-Zhu, Huang Mao, Zhang Li-Shan
机构信息
Department of Respiratory Medicine, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, 100039, China.
Department of Respiratory Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
出版信息
Chin J Integr Med. 2021 May;27(5):375-378. doi: 10.1007/s11655-020-3485-9. Epub 2021 Feb 2.
Abstract
摘要
相似文献
1
Thoughts on Traditional Chinese Medicine Treatment of Novel Coronavirus Pneumonia Based on Two Cases.基于两例病例对新型冠状病毒肺炎的中医治疗思考
Chin J Integr Med. 2021 May;27(5):375-378. doi: 10.1007/s11655-020-3485-9. Epub 2021 Feb 2.
2
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效：一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
3
East meets West in COVID-19 therapeutics.在新冠病毒治疗中，东西方相遇了。
Pharmacol Res. 2020 Sep;159:105008. doi: 10.1016/j.phrs.2020.105008. Epub 2020 Jun 9.
4
Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.采用 ACE2/CMC-HPLC-IT-TOF-MS 方法从麻黄中筛选和评价抗 SARS-CoV-2 成分。
Anal Bioanal Chem. 2021 May;413(11):2995-3004. doi: 10.1007/s00216-021-03233-7. Epub 2021 Feb 19.
5
Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).麻黄-甘草药对防治 2019 年冠状病毒病（COVID-19）的化学成分和药理机制。
Aging (Albany NY). 2021 Feb 13;13(4):4811-4830. doi: 10.18632/aging.202622.
6
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.中药配方联合西药治疗 COVID-19 危重症病例。
Complement Ther Med. 2020 Aug;52:102473. doi: 10.1016/j.ctim.2020.102473. Epub 2020 Jun 9.
7
The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.中药治疗儿童新型冠状病毒肺炎的有效性和安全性。
Medicine (Baltimore). 2020 Jul 24;99(30):e21247. doi: 10.1097/MD.0000000000021247.
8
Current State of Research About Chinese Herbal Medicines (CHM) for the Treatment of Coronavirus Disease 2019 (COVID-19): A Scoping Review.关于中药（CHM）治疗 2019 年冠状病毒病（COVID-19）的研究现状：范围综述。
J Altern Complement Med. 2020 Jul;26(7):557-570. doi: 10.1089/acm.2020.0189. Epub 2020 Jun 24.
9
Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients.基于网络药理学方法阐释中药治疗新冠肺炎患者的作用机制
Pharmacol Res. 2020 Sep;159:105043. doi: 10.1016/j.phrs.2020.105043. Epub 2020 Jun 20.
10
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
引用本文的文献
1
Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.化湿败毒颗粒治疗新型冠状病毒奥密克戎变异株感染患者的有效性和安全性：一项单中心回顾性队列研究。
Chin J Integr Med. 2024 Feb;30(2):107-114. doi: 10.1007/s11655-023-3549-8. Epub 2023 May 24.
2
Study on Intelligent Traditional Chinese Medicine Fumigation for Treating Lumbar Intervertebral Disc Herniation Based on Medical Big Data Mining.基于医学大数据挖掘的智能中医熏蒸治疗腰椎间盘突出症的研究。
Contrast Media Mol Imaging. 2022 Oct 13;2022:4658192. doi: 10.1155/2022/4658192. eCollection 2022.
3
Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19: A case report.重症 COVID-19 患者采用综合治疗性血浆置换与中医药治疗：一例报告。
J Integr Med. 2022 Nov;20(6):575-580. doi: 10.1016/j.joim.2022.09.001. Epub 2022 Sep 3.
4
Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology.基于网络药理学的大元汤治疗发热的分子机制。
Comput Math Methods Med. 2022 Mar 25;2022:7422383. doi: 10.1155/2022/7422383. eCollection 2022.
Zotero 插件